Your Article Summary
Assessment of cardiovascular risk in waiting-listed renal transplant patients: a single center experience in 558 cases
Clinical Transplantation, 06/30/09
Leonardi G et al. - It is suggested that not increased cardiovascular event or deaths rates in the high-risk group reflect early coronary lesion detection and correction. Since 55.9% of cardiovascular events or deaths occurred in the negative group more than 24 months after the DMS, its mandatory repetition every two yr after a negative finding is recommended.
Related Articles
Allogeneic hematopoietic stem cell transplantation (alloSCT) for chronic myeloid leukemia in the imatinib era; Evaluation of its impact within a subgroup of the randomized German CML Study IV
Blood, 11/20/09
Relevance Score: 94%
Aerosolized vancomycin for the treatment of MRSA after lung transplantation
Respirology, 11/10/09
Relevance Score: 94%
Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation
Pediatric Blood & Cancer, 11/05/09
Relevance Score: 94%
Soluble CD30 Levels in Recipients Undergoing Heart Transplantation Do Not Predict Post-transplant Outcome
The Journal of Heart and Lung Transplantation, 10/28/09
Relevance Score: 94%
Fulminant Hepatic Failure due to Varicella Zoster in a Heart Transplant Patient: Successful Liver Transplant
The Journal of Heart and Lung Transplantation, 10/28/09
Relevance Score: 93%
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Statin Therapy Ameliorates Renal Allograft Function
Transplantation Proceedings, 12/18/09
Pilot Study: Association of Traditional and Genetic Risk Factors and New-Onset Diabetes Mellitus Following Kidney Transplantation
Transplantation Proceedings, 12/18/09
Effects of Cyclosporine-Tacrolimus Switching in Posttransplantation Hyperlipidemia on High-Density Lipoprotein 2/3, Lipoprotein A1/B, and Other Lipid Parameters
Transplantation Proceedings, 12/18/09

See Latest Articles